A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of ...
Dec 10, 2022
0
4455
The pharmaceutical firm Regeneron on Monday announced it was entering the late stages of its human clinical trials investigating a drug to both treat and prevent COVID-19.
Jul 6, 2020
0
171
University of South Florida Distinguished Professor Benjamin Djulbegovic, MD, PhD, has studied the ethics of randomized clinical trials and their effectiveness in evaluating the outcomes of new treatments for decades.
Aug 27, 2013
0
0
Behind the chubby cheeks and bright eyes of babies as young as 8 months lies the smoothly whirring mind of a social statistician, logging our every move and making odds on what a person is most likely to do next, suggests ...
Jul 27, 2017
1
694
A Phase 1 clinical trial conducted by University of Minnesota researchers has demonstrated the safety and efficacy of a novel immunotherapy drug in the treatment of human immunodeficiency virus (HIV). Results of the trial ...
Feb 1, 2022
0
65
A team of medical researchers and doctors affiliated with several universities and two hospitals in the U.S. reports that administration of vitamin D2 to patients newly diagnosed with diabetes type 1 can prolong the so-called ...
Melanoma of the eye (ocular or uveal melanoma) frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients ...
Sep 23, 2011
0
0
A new study by a University of Arkansas information systems researcher and his colleague at the University of Waikato in New Zealand shows that COVID vaccine trials conducted in geographic locations with low infection rates ...
May 24, 2022
0
105
The monoclonal antibodies cinpanemab and prasinezumab show almost no benefit for early Parkinson disease, according to two phase 2 trials published in the Aug. 4 issue of the New England Journal of Medicine.
Aug 4, 2022
0
2
A drug which 'reboots' a person's immune system has been shown to be an effective treatment for multiple sclerosis (MS) patients who have already failed to respond to the first drug with which they were treated (a 'first-line' ...
Oct 31, 2012
0
0
